WallStreetZen

NYSE: DHR
Danaher Corp Earnings & Revenue

DHR past earnings growth

How has DHR's earnings growth performed historically?
Company
59.44%
Industry
179.22%
Market
104.53%
DHR's earnings have grown slower (17.18% per year) than the US Diagnostics & Research industry average (64.74%)
Performance
DHR's earnings have grown slower (17.18% per year) than the US market average (31.1%)
Performance
DHR's earnings growth is accelerating - its growth over the last year (59.44%) is above its 5-year compound annual rate (17.18%)
Performance

DHR past revenue growth

How has DHR's revenue growth performed historically?
Company
37.63%
Industry
39.89%
Market
41.42%
DHR's revenue has grown slower (11.05% per year) than the US Diagnostics & Research industry average (18.88%)
Performance
DHR's revenue has grown slower (11.05% per year) than the US market average (19.51%)
Performance
DHR's revenue growth is accelerating - its growth over the last year (37.63%) is above its 5-year compound annual rate (11.05%)
Performance

DHR earnings and revenue history

Current Revenue
$28.1B
Current Earnings
$5.7B
Current Profit Margin
20.4%
DHR's has demonstrated consistent long-term earnings growth over the past 10 years (158.71%)
Performance

DHR Return on equity

Current Company
13.8%
Current Industry
16.8%
Current Market
21.6%
DHR's Return on Equity (13.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

DHR Return on assets

Current Company
7.3%
Current Industry
5.8%
DHR is generating lower Return on Assets (7.3%) than the US Diagnostics & Research industry average (8.62%)
Performance

DHR Return on capital employed

Current Company
9.83%
Current Industry
9.1%
DHR has gotten more efficient at generating Return on Capital (9.83%) compared to 3 years ago (7.8%)
Performance

Danaher Corp Earnings & Revenue FAQ

What were DHR's earnings last quarter?

On Invalid Date, Danaher Corp (NYSE: DHR) reported Q3 2021 earnings per share (EPS) of $1.56, up 32.2% year over year. Total Danaher Corp earnings for the quarter were $1.12 billion. In the same quarter last year, Danaher Corp's earnings per share (EPS) was $1.18.

What was DHR's earnings growth in the past year?

As of Q4 2021, Danaher Corp's earnings has grown 59.44% year over year. This is 119.78 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 179.22%. Danaher Corp's earnings in the past year totalled $5.72 billion.

What was DHR's revenue last quarter?

On Invalid Date, Danaher Corp (NYSE: DHR) reported Q3 2021 revenue of $7.23 billion up 22.86% year over year. In the same quarter last year, Danaher Corp's revenue was $5.88 billion.

What was DHR's revenue growth in the past year?

As of Q4 2021, Danaher Corp's revenue has grown 37.63% year over year. This is 2.26 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 39.89%. Danaher Corp's revenue in the past year totalled $28.07 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.